Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Paratek Pharmaceuticals
Biotech
Paratek’s omadacycline sails through AdComm en route to October nod
An FDA advisory committee voted in favor of Paratek’s new antibiotic for acute bacterial skin infections and community-acquired bacterial pneumonia.
Amirah Al Idrus
Aug 9, 2018 8:15am
FDA tells advisory panel Paratek’s antibiotic is ‘noninferior’
Aug 7, 2018 11:32am
Paratek rising fast after report says it is for sale
Aug 23, 2017 9:38am
China’s Zai Lab files for $115M Nasdaq IPO
Aug 16, 2017 8:20am
Paratek antibiotic hits endpoints in phase 3, teeing up NDA
Jul 18, 2017 4:11am
Paratek shares surge after antibiotic phase 3 hits endpoints
Apr 4, 2017 10:07am
